Veterans with obesity report poorer health status and more disability days compared to veterans without obesity
While peptide therapy may possess significant therapeutic and regenerative potential, it is critical that orthopedic and sports medicine providers understand the current lack of evidence to support the clinical use of these peptides, the authors concluded
single-dose vials should be used immediately after opening
Tirzepatide (Mounjaro, Zepbound), a dual GIP/GLP-1 receptor agonist, reports injection site reaction rates of approximately 1.7-2.2% in its FDA prescribing information, similar to semaglutide
UA has received honoraria from Procter & Gamble, Viatris, Grunenthal and Sanofi for educational meetings
Who It's For: Anyone looking to reduce signs of aging